Lipid-lowering therapy should be avoided in insulin-sensitive individuals concerned about its impact on macrophages.

“there is a strong case that we should consider avoided liping Ling therapy if someone is of a different context like we're talking about now again these are my words not Dave's um and again this is not medical advice this is just my perspective as a human that tends to be pretty darn insulin sensitive you're you're correctly sensitive especially at this time um for why it is that I would be more sensitive to how much this could affect anybody's uh medical decision-making with their doctor particularly with medication and again this is why I brought up with the inv vitro study on the macras that lipid lowering therapy might literally have an impact on the macr fases themselves”